Document is current
Any future updates will be listed below
-
Authors
Kantor, Elizabeth D. https://orcid.org/0000-0002-9124-5323
O’Connell, Kelli
Ergas, Isaac J.
Valice, Emily
Roh, Janise M.
Bhimani, Jenna
Heon, Narre
Griggs, Jennifer J.
Lee, Jean
Bowles, Erin JA
Rivera, Donna R.
Kolevska, Tatjana
Bandera, Elisa V
Kushi, Lawrence H
-
Funding
Funding for this research was provided by:
National Cancer Institute (U24 CA171524)
National Cancer Institute (R37CA222793)
National Cancer Institute (R01 CA105274)
National Cancer Institute (U01 CA195565)
National Cancer Institute (R50CA211115)
Geoffrey Beene Cancer Research Center at Memorial Sloan Kettering Cancer Center (Geoffrey Beene Cancer Research Center at Memorial Sloan Kettering Cancer Center)
- License Information
-
More Information
Article History
Received: 20 July 2023
Accepted: 9 September 2023
First Online: 4 November 2023
Declarations
:
: Dr. Bandera serves in an Advisory Board for Pfizer Clinical Trial Diversity Initiative. Other authors have no conflicts of interest to declare.
